Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets

Trial Profile

Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms SPECIALIST
  • Most Recent Events

    • 29 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01670318).
    • 21 Aug 2012 Status changed from not yet recruiting to recruiting.
    • 16 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top